Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Hristina Byrnes | Nov 19, 2019 at 8:47 AM EST

This Is the Unhealthiest State in America

The unhealthiest state in the union, according to statistics compiled by LetsGetChecked, a home health and wellness testing site, is…

Jon C. Ogg | Nov 18, 2019 at 4:22 PM EST

New Schizophrenia Study May Usher in Game-Changing Standard of Care

On top of the potential game-changer for schizophrenia patients, some Karuna Therapeutics investors just experienced the same euphoria as holding…

Trey Thoelcke | Nov 18, 2019 at 7:45 AM EST

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.

Paul Ausick | Nov 16, 2019 at 1:57 PM EST

Health Care Data Breaches May Cost More Than Money

Cybercrime against health care organizations is rising and it is not only costing the victims money, it lowers their quality…

Jon C. Ogg | Nov 15, 2019 at 11:20 AM EST

resTORbio Becomes Next Biotech Implosion, and Other Indications May Not Matter

There is a huge risk-reward factor in emerging pharmaceutical and biotech companies that happen to have all their eggs in…

Paul Ausick | Nov 14, 2019 at 12:43 PM EST

The Threat From Antibiotic-Resistant Germs Gets Scarier

In a new report on antibiotic-resistant germs, the CDC highlights the rising levels of risk and what we must do…

Chris Lange | Nov 12, 2019 at 4:22 PM EST

Is Tilray’s Growth Enough for Investors?

Tilray released its third quarter financial results after the closing bell on Tuesday. The company said that it had a…

Chris Lange | Nov 12, 2019 at 11:36 AM EST

Is This DMD Study Sunk After FDA Update?

Solid Bio shares were absolutely crushed on Tuesday after the firm announced that the FDA has placed its Ignite DMD…

Chris Lange | Nov 12, 2019 at 10:00 AM EST

Major Biotechs See Rising Tide in Short Interest

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data…

Chris Lange | Nov 12, 2019 at 8:50 AM EST

Big Pharma Scares Off Short Sellers

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Nov 11, 2019 at 12:38 PM EST

Is Vaping Really Worse Than Smoking?

Two new studies that will be reported later this week suggest a link between using e-cigarettes and reduced heart health.

Chris Lange | Nov 11, 2019 at 12:05 PM EST

Why Investors Are Pumping the Brakes on NextCure’s Cancer Treatment

NextCure updated clinical results from its early stage cancer study at the Society for Immunotherapy of Cancer annual meeting. As…

Chris Lange | Nov 11, 2019 at 11:00 AM EST

Is This FDA Update the Death of Lipocine?

Lipocine shares absolutely plummeted on Monday after the firm announced that it received a Complete Response Letter from the FDA…

Chris Lange | Nov 11, 2019 at 9:35 AM EST

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Nektar Therapeutics shares made a handy gain on Monday after the firm announced updated results from its first-in-human Phase 1a…

Chris Lange | Nov 8, 2019 at 10:35 AM EST

Melanoma Treatment Takes a Big Step Forward

Iovance Bio shares jumped on Friday after the firm announced results from its mid-stage metastatic melanoma study.

1 … 78 79 80 81 82 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

This Is the Unhealthiest State in America

New Schizophrenia Study May Usher in Game-Changing Standard of Care

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Health Care Data Breaches May Cost More Than Money

resTORbio Becomes Next Biotech Implosion, and Other Indications May Not Matter

The Threat From Antibiotic-Resistant Germs Gets Scarier

Is Tilray’s Growth Enough for Investors?

Is This DMD Study Sunk After FDA Update?

Major Biotechs See Rising Tide in Short Interest

Big Pharma Scares Off Short Sellers

Is Vaping Really Worse Than Smoking?

Why Investors Are Pumping the Brakes on NextCure’s Cancer Treatment

Is This FDA Update the Death of Lipocine?

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Melanoma Treatment Takes a Big Step Forward

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

This Is the Unhealthiest State in America

New Schizophrenia Study May Usher in Game-Changing Standard of Care

AbbVie, Cigna and Other Health Care Stocks With Recent Golden Crosses

Health Care Data Breaches May Cost More Than Money

resTORbio Becomes Next Biotech Implosion, and Other Indications May Not Matter

The Threat From Antibiotic-Resistant Germs Gets Scarier

Is Tilray’s Growth Enough for Investors?

Is This DMD Study Sunk After FDA Update?

Major Biotechs See Rising Tide in Short Interest

Big Pharma Scares Off Short Sellers

Is Vaping Really Worse Than Smoking?

Why Investors Are Pumping the Brakes on NextCure’s Cancer Treatment

Is This FDA Update the Death of Lipocine?

Why This Early-Stage Autoimmune and Chronic Inflamatory Trial May Be a Big Hit

Melanoma Treatment Takes a Big Step Forward

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500